Cocrystal Pharma Files Q1 2025 10-Q
Ticker: COCP · Form: 10-Q · Filed: May 15, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Cocrystal Pharma filed its Q1 2025 10-Q. Check financials.
AI Summary
Cocrystal Pharma, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as BIOZONE PHARMACEUTICALS, INC., is based in Bothell, WA. This filing provides financial updates and operational details for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Cocrystal Pharma, Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cocrystal Pharma faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-15 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Filer of the 10-Q report
- BIOZONE PHARMACEUTICALS, INC. (company) — Former name of Cocrystal Pharma, Inc.
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Date the report was filed
- Bothell, WA (location) — Company's business address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What was Cocrystal Pharma, Inc. previously named?
Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC.
Where is Cocrystal Pharma, Inc. located?
Cocrystal Pharma, Inc. is located in Bothell, WA.
What is the Standard Industrial Classification for Cocrystal Pharma, Inc.?
The Standard Industrial Classification for Cocrystal Pharma, Inc. is Pharmaceutical Preparations [2834].
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Cocrystal Pharma, Inc. (COCP).